SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (14209)7/24/2000 8:53:57 AM
From: Robert K.  Read Replies (1) | Respond to of 17367
 
Bluegreen, I am envious that you got to that article before I. Nice find. Here is a little known "other" article. I have read it in full text (must pay to read.)
Its quite a impressive article, highly recommended reading.
You should read it asap. Again notice the (s) in the title.

>Potential Applications of N-Terminal Recombinant Fragments of Bactericidal/Permeability-Increasing Protein in Liver Surgery
Marinus J. Wiezer, Catharina Meijer, Hubert A. Prins, Sybren Meijer, and Paul A.M. van Leeuwen
Liver Transpl. 1999 5: 126-135



To: Bluegreen who wrote (14209)7/25/2000 11:27:17 PM
From: Cacaito  Respond to of 17367
 
"SIGNIFICANT" business in a significant human study is what matters.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News